Welcome to our dedicated page for RCM TECHNOLOGIES SEC filings (Ticker: RCMT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
RCM Technologies, Inc. filings document the reporting obligations of a Nevada-incorporated operating company with common stock registered on Nasdaq under the symbol RCMT. Its Form 8-K reports cover financial results, material agreements, revolving credit and loan amendments, direct financial obligations, changes in certifying accountants, and related internal control disclosures.
The company’s proxy materials address board matters, executive compensation, equity award information, and pay-versus-performance disclosure. Periodic and notice filings provide formal records around annual reporting, late-filing notifications, consolidated financial statements, risk and control matters, and the governance framework supporting RCM Technologies’ health care, engineering, information technology, life sciences, data, and solutions services.
RCM TECHNOLOGIES, INC. (RCMT) reported that its CFO, Kevin D. Miller, sold a total of 22,501 shares of common stock in two open-market transactions. On August 28, 2026, he sold 2,230 shares at $42.00 per share. On August 31, 2026, he sold 20,271 shares at a weighted-average price of $42.19 per share, within a range of $42.00 to $42.95. The company states these were nondiscretionary sales executed under a Rule 10b5-1 trading plan established on August 12, 2024.
RCM TECHNOLOGIES, INC. (RCMT) officer Kevin D. Miller filed a Rule 144 notice indicating an intention to sell up to 20,000 shares of common stock, par value $0.05 per share, through broker Baird. The shares are valued at an aggregate of $840,000.00, with 7,110,759 shares outstanding as of August 12, 2026. The notice also lists prior sales of RCM common stock by Miller during the past three months and states that his holdings were acquired via salary exchange, the company ESPP, equity compensation, and open market purchases.
RCM Technologies, Inc. (RCMT) reported that on August 13, 2026 its Compensation Committee approved an equity grant under the 2014 Omnibus Equity Compensation Plan to Executive Chairman and President Bradley S. Vizi of up to 125,000 performance stock units (PSUs). PSU vesting for a performance period from January 4, 2026 to January 2, 2027 will be based 50% on EBITDA achievement and 50% on individual performance goals, with threshold, target and maximum levels of 25,000, 50,000 and 62,500 PSUs, respectively. The award provides for accelerated vesting upon a Change in Control, death or disability. On the same date, the Committee granted time-based restricted stock units (RSUs) under the Plan to two executives: 8,362 RSUs to Kevin D. Miller and 4,000 RSUs to Michael Saks, each vesting in a single installment on the fifth anniversary of grant, subject to continued employment, with accelerated vesting upon death, disability or a covered termination following a change in control.
RCM TECHNOLOGIES, INC. (RCMT) reported insider transactions by Chief Financial Officer Kevin D. Miller. On August 25, 2026, he sold 1,333 shares of common stock at a weighted average price of about $42.00 per share, within a price range of $42.00 to $42.04. On August 26, 2026, he sold an additional 1,753 shares at a weighted average price of about $42.05 per share, within a price range of $42.00 to $42.15. In total, 3,086 shares were sold in open market or private transactions pursuant to a nondiscretionary Rule 10b5-1 trading plan established on August 12, 2024.
RCM TECHNOLOGIES, INC. (RCMT) reported that officer Michael Saks, Division President, HC Services, had 706 shares of Common Stock sold on 2026-08-21 at $41.12 per share. According to the footnote, these shares were sold solely to cover the payment of withholding taxes on the vesting of previously reported performance-based RSUs. Following this tax-related sale, Saks directly held 88,601 shares of RCMT common stock.
RCM TECHNOLOGIES, INC. (RCMT) is the issuer for a Form 144 notice filed for the account of officer Michael Saks. The notice relates to common stock, par value $0.05 per share, linked to performance-based RSUs and handled through Morgan Stanley Smith Barney LLC Executive Financial Services. The filing also lists recent sales of RCM common stock by Saks over the prior three months.
RCM TECHNOLOGIES, INC. (RCMT) officer Michael Saks, Division President, HC Srvs., reported two open‑market sales of common stock on 2026-08-18 totaling 10,000 shares. The sales were executed at weighted-average prices of $40.78 and $41.24, each representing ranges of individual sale prices disclosed in footnotes.
RCM Technologies, Inc. (RCMT) reported insider transactions by its CFO, Kevin D. Miller, who sold a total of 94,413 shares of Common Stock in open-market transactions between August 14 and August 18, 2026. Sales occurred at weighted-average prices including $34.02, $36.46, $37.49, $38.06, $39.12, and $42.00 per share, each reflecting ranges disclosed in the footnotes. All sales were made pursuant to a nondiscretionary Rule 10b5-1 trading plan established on August 12, 2024.
RCM Technologies, Inc. (RCMT) officer Michael Saks filed a notice to sell up to 10,000 shares of common stock through Morgan Stanley Smith Barney, with an aggregate market value of $410,709.12 and 7,110,759 shares outstanding as of August 18, 2026. Saks previously sold 11,792 shares for $395,753.58 on August 14, 2026.
RCM Technologies, Inc. (RCMT) director, executive chairman and president Bradley Vizi reported selling a total of 100,000 shares of common stock in open-market transactions. On August 14, 2026, he sold 25,281 shares at a weighted-average price of $35.02 (range $35.00–$35.41). On August 17, 2026, he sold 24,719 shares at a weighted-average price of $36.42 (range $36.03–$37.10) and 50,000 shares at a weighted-average price of $40.06 (range $40.00–$40.56). The sales were executed under a nondiscretionary Rule 10b5-1 trading plan established on December 7, 2023.